AMN Healthcare Services Inc: Form 10-Q for the period ended Sep 30, 2016
Filed with the SEC on Nov 4, 2016 and accepted by EDGAR at Nov 4, 2016, 16:43 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-07-01 to 2016-09-30 | $472.6m | us-gaap:Revenues |
| Revenue | 9 months2016-01-01 to 2016-09-30 | $1.41bn | us-gaap:Revenues |
| Cost of revenue | 3 months2016-07-01 to 2016-09-30 | $318.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2016-01-01 to 2016-09-30 | $953.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2016-07-01 to 2016-09-30 | $154.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2016-01-01 to 2016-09-30 | $461.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2016-07-01 to 2016-09-30 | $100.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2016-01-01 to 2016-09-30 | $297.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2016-07-01 to 2016-09-30 | $46.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2016-01-01 to 2016-09-30 | $141.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2016-07-01 to 2016-09-30 | $3.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2016-01-01 to 2016-09-30 | $9.1m | us-gaap:InterestExpense |
| Income tax | 3 months2016-07-01 to 2016-09-30 | $16.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2016-01-01 to 2016-09-30 | $53.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2016-07-01 to 2016-09-30 | $27.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2016-01-01 to 2016-09-30 | $79.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-07-01 to 2016-09-30 | $0.55 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2016-01-01 to 2016-09-30 | $1.61 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-07-01 to 2016-09-30 | $0.57 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2016-01-01 to 2016-09-30 | $1.66 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2016-07-01 to 2016-09-30 | 49,410,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2016-01-01 to 2016-09-30 | 49,287,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2016-01-01 to 2016-09-30 | $84.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2016-01-01 to 2016-09-30 | $17.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-09-30 | $15.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-09-30 | $433.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-09-30 | $1.17bn | us-gaap:Assets |
| Current liabilities | At period end2016-09-30 | $240.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-09-30 | $736.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-09-30 | $433.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-16-000024. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.